All In MedTech

Device Trial Radar · NCT05791344

Intra-procedural ECG Changes During TAVR

Last checked: Nov 20, 2026Latest source record: Jun 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

43

Actual

Start

Jun 21, 2023

Primary completion

Jul 23, 2024

Study completion Dec 31, 2024

Sponsor

Lead sponsor
Cara Medical LtdNot on our public-company list
Sponsor type
Industry
First posted
Mar 30, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate electrocardiogram (ECG) changes in 100 patients undergoing transcatheter aortic valve replacement (TAVR) to assess new-onset conduction abnormalities, such as atrioventricular nodal block (AVB) (1st, 2nd, or 3rd degree), or new-onset left bundle branch block (LBBB) that may occur during the procedure. Eligible patients enrolled in this study will be monitored with an FDA-approved ECG Holter system during TAVR, to assess intra-procedural changes. This will be a small-scale, early feasibility study performed to inform a future, larger-scale prospective investigation.

Conditions

  • Transcatheter Aortic Valve Replacement
  • Conduction Disturbance

Interventions

  • ECG monitoringDevice

    Intra-procedural ECG changes during TAVR

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Identifying ECG changes during the TAVR procedureTime frame: 14 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The Weill Cornell Medicine

    New York, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.